CALR versus JAK2mutated essential thrombocythaemia - a report on 141 patients-Reference-Cited by-同舟云学术

CALR versus JAK2mutated essential thrombocythaemia - a report on 141 patients

Published:2014-08-08 Issue:1 Volume:168 Page:151-153
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Trifa Adrian P.¹^ORCID,Popp Radu A.¹,Cucuianu Andrei²,Bănescu Claudia³,Tevet Mihaela⁴,Martin Bianca¹,Murat Meilin⁴,Vesa Ştefan C.⁵,Dima Delia²,Cândea Marcela⁶,Militaru Mariela S.¹,Pop Ioan V.¹

Affiliation:

1. Department of Medical Genetics; “Iuliu Haţieganu” University of Medicine and Pharmacy; Cluj-Napoca Romania

2. Department of Haematology; “Ion Chiricuţă” Cancer Institute; Cluj-Napoca Romania

3. Department of Genetics; University of Medicine and Pharmacy; Tîrgu-Mureş Romania

4. Department of Haematology; Colentina Hospital; Bucharest Romania

5. Department of Pharmacology; “Iuliu Haţieganu” University of Medicine and Pharmacy; Cluj-Napoca Romania

6. First Clinic of Haematology; University of Medicine and Pharmacy; Tîrgu-Mureş Romania

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bjh.13076/fullpdf

Reference8 articles.

1. Detection of MPL mutations by a novel allele-specific PCR-based strategy;Furtado;The Journal of Molecular Diagnostics,2013

2. Widespread occurrence of the JAK2 V617F mutation in chronic myeloproliferative disorders;Jones;Blood,2005

3. Somatic mutations of calreticulin in myeloproliferative neoplasms;Klampfl;The New England Journal of Medicine,2013

4. Somatic CALR mutations in myeloproliferative neoplasms with nonmutated JAK2;Nangalia;The New England Journal of Medicine,2013

5. Impact of calreticulin mutations on clinical and hematological phenotype and outcome in essential thrombocythemia;Rotunno;Blood,2014

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of CALR and JAK2V617F Mutations on Clinical Course and Disease Outcomes in Essential Thrombocythemia: A Multicenter Retrospective Study in Turkish Patients;Turkish Journal of Hematology;2024-03-04

2. Comparative thrombotic risk associated with CALR1, CALR2, and JAK2 V617F mutations in essential thrombocythemia;American Journal of Hematology;2023-11-11

3. Hematological relevance of JAK2 V617F and calreticulin mutations in Tunisian patients with essential thrombocythemia;Journal of Clinical Laboratory Analysis;2022-06-26

4. MYELOPROLIFERATIVE AND MYELODYSPLASTIC/MYELOPROLIFERATIVE NEOPLASMS AND RELATED CONDITIONS;Bone Marrow Pathology;2019-03-08

5. Modest contribution of JAK2 V617F allele burden to the occurrence of major thrombosis in polycthemia vera and essential thrombocythemia;Blood Cells, Molecules, and Diseases;2018-11